EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2022
TABLES
122
PAGES
212
EDITION
17
PRICE
USD 5600
CODE
MCP-1476
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
SELECT PLAYERS
Ablynx NV; Arrowhead Pharmaceuticals Inc.; CaPtivate Pharmaceuticals LLC; Celgene Corporation; ELITechGroup; Flamel Technologies SA; GlaxoSmithKline Plc; Johnson & Johnson; Merck & Co. Inc.; NanoBio® Corporation; Nanophase Technologies Corporation; pSivida Corp.; Sigma-Aldrich Corp.; Starpharma Holdings Ltd.; Vectura Group plc
SEGMENTS
» End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
A Curtain Raiser |
Recent Market Activity |
Nanobiotechnology - The Next Big Thing |
An Insight into the Global Nanobiotechnology Market |
Major Market Drivers |
Where Conventional Molecular Science Falls Short…Nanobio Steps In |
Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector |
Nanomedicine Market to Achieve Phenomenal Growth |
Opportunities Galore for Nanomedicine |
Drug Delivery - A Promising Application Area for Nanotechnology |
Nanotechnology Offers Huge Potential in Brain Disorder Treatment |
High Demand for Nanobots and Nano Healthcare Devices |
Nanotechnology Gaining Prominence for Treatment of Cancer |
Nanotechnology in Drug Delivery: A Specialized Market Opportunity |
Commercialization of Nanotechnology-based Medical Products Gains Momentum |
Nanodiagnostic Products to Witness Strong Demand Growth |
Dendrimers Serve as a Base to Build Multifunctional Nanodevices |
Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment |
Huge Opportunities for Nanomaterials in the Medical Field |
Commercial Opportunities in Healthcare Sector |
Future Possibilities |
Global Market for Fullerenes - An Insight |
Dawn Breaks on Nanobiotechnology |
Demystifying the Intriguing World of Nanobiotech |
A Meeting Place of Medicine’s Best Solutions |
Nanobiotechnology to Become Viable for All Drug Development Stages |
Nanoparticles: The Foundation of Nanobiotechnology |
Improved Optical Properties and Stability of Nanoparticles |
Nanoemulsions |
The Promise of Nanobiotechnology |
Biological Weaponries against Diseases Come in Small Packages |
Proffered Benefits of Nanobiotechnology |
Opportunity & Beyond |
Nanobiotechnology - Will it Live Up to the Expectations? |
The Future of Nanobiotechnology: Shape of Things to Come |
Nanobiotechnology: The Outer Limits |
Futuristics: A Rumination |
Conclusions |
Nanobiotechnology – Global Key Competitors Percentage Market Share in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
2. FOCUS ON SELECT PLAYERS |
Ablynx NV (Belgium) |
Arrowhead Pharmaceuticals, Inc. (USA) |
Avadel Pharmaceuticals plc (Ireland) |
CaPtivate Pharmaceuticals LLC (USA) |
Celgene Corporation (USA) |
ELITechGroup (France) |
GlaxoSmithKline Plc. (UK) |
Johnson & Johnson (USA) |
Merck & Co., Inc. (USA) |
NanoBio® Corporation (USA) |
Nanophase Technologies Corporation (USA) |
pSivida Corp. (USA) |
Sigma-Aldrich Corp. (USA) |
Starpharma Holdings Ltd. (Australia) |
Vectura Group plc (UK) |
3. MARKET TRENDS & DRIVERS |
Present Status and Future Opportunities |
Outlook |
Developing Countries to Rise over the Horizon |
Nanomaterials & Nanoparticles Witness Robust Activity |
Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials |
Why Invest in Nanobiotechnology? |
Private and Public Companies to Step Up Funding on Nanotechnology |
United States Lead the Way in Government Funding |
Increasing Awareness on Technology to Drive Growth |
Demand for Novel Products to Push Up Growth |
Nano-Enabled Drug Discovery Holds Tremendous Potential |
Consolidation Sharpens the Industry's Edge |
The Regulatory Framework Evolves with the Technology |
Quantum Dot Patents Pose Legal Tangles |
Miniaturized Liquid Handling Becomes Progressive |
Trends in Nanotechnology Enabled Drug Delivery Systems |
Patent Expiries: A Key Driver |
Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
JAPAN |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
CHINA |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
EUROPE |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
FRANCE |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
GERMANY |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 79 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com